A Texas-based biotech be­comes the lat­est to en­ter the SPAC scene

A biotech lo­cat­ed in Texas’ cap­i­tal will be look­ing to en­ter a SPAC deal.

On Mon­day, the Dal­las-based SPAC Fi­nan­cial Strate­gies Ac­qui­si­tion Corp. an­nounced it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.